Pipeline

We're tackling cancer with a new approach by identifying disease-specific, pathologic conformers, and targeting the most efficacious epitopes on those targets.

We're tackling cancer with a new approach by identifying disease-specific, pathologic conformers, and targeting the most efficacious epitopes on those targets.

Get In Touch.
Let's Talk

© Copyright 2024 Immuto Therapeutics. All rights reserved.